Clinical Trial Update: Study of 7-valent Pneumococcal Conjugate Vaccine in Children With Idiopathic Nephrotic Syndrome [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the 7-valent pneumococcal conjugate vaccine in children with idiopathic nephrotic syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Nephrotic Syndrome

Drugs mentioned

• Prevnar 7 (Pneumococcal conjugate vaccine, 7-valent)

Snippet

Sponsor: National and Kapodistrian University of Athens | Conditions: Idiopathic Nephrotic Syndrome | Phase 4 | Status: UNKNOWN